This episode is part of a limited series called Money Ball in conjunction with the BLPN Club. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.

In this episode of The Healthy Enterprise, host Heath Fletcher interviews Doug Cohen, the Co-Founder and CEO of IR Medtek, about his journey in developing a groundbreaking technology for cancer detection. Doug shares his unique background in mechanical engineering and how it led him to identify a significant gap in the healthcare market, particularly in skin cancer detection. The conversation delves into the development process of their innovative device, the challenges faced, and the importance of refining their pitch to investors through the Money Ball program. Doug emphasizes the value of collaboration, confidence in their technology, and the potential impact on patient care.

Chapters:
00:00 Introduction to Money Ball and IR Medtek
01:14 Doug's Unique Background and Journey
02:27 Identifying the Gap in Cancer Detection
05:51 The Development Journey of the Technology
07:41 Current Progress and Future Steps
08:39 Understanding the Device and Its Functionality
10:58 Enhancing Primary Care with Technology
13:25 Investor Response and Presentation Experience
14:34 Refining the Pitch through Money Ball
18:32 Public Speaking and CEO Responsibilities
21:12 The Advantage of an Engineering Background
24:11 Reflections on the Money Ball Experience

Guest Information:

• Guest's Name: Doug Cohen
• Guest's Title/Position: Chief Executive Officer
• Guest's Linkedin: https://www.linkedin.com/in/doug-cohen-64761410/
• Company / Affiliation: IR Medtek https://www.irmedtek.com/
• Guest's Bio:  Doug Cohen is IR Medtek's Co-Founder and CEO and has over 20 years of experience in manufacturing equipment, product design, global sourcing, and logistics. Doug is a graduate of MIT in mechanical engineering and has experience as both an owner and investor in start-ups. He owns a number of technology patents and serves on the board of the public company Organovo.

Takeaways:

• Doug's background in mechanical engineering shaped his approach to IR Medtek.
• The technology developed can differentiate tumor from non-tumor tissue.
• Skin cancer detection is a significant market opportunity.
• The device provides real-time feedback to primary care doctors.
• Investor confidence is crucial for the success of startups.
• Refining the pitch can significantly improve investor engagement.
• Public speaking skills are essential for CEOs in fundraising.
• Collaboration with experts enhances the team's capabilities.
• The Money Ball program provided valuable networking opportunities.
• The technology has the potential to improve patient outcomes significantly.

The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/